首页 > 最新文献

Gastroenterology Research最新文献

英文 中文
Flood Syndrome. 洪水综合症。
IF 1.5 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2022-08-01 Epub Date: 2022-08-23 DOI: 10.14740/gr1508
Jia Li Lee, Jeffrey Jiang

Flood syndrome refers to the exsanguination of ascitic fluid following the spontaneous rupture of an umbilical hernia, and is a rare complication of liver cirrhosis with ascites. In this case report, we describe a 67-year-old patient with Flood syndrome who was initially managed conservatively in a community hospital run by primary care physicians, prior to transfer to a tertiary hospital for specialist surgical review and management. We also performed a literature review of the current treatment modalities to manage this condition.

洪水综合征是指脐带疝自发性破裂后腹水出血,是肝硬化伴腹水的罕见并发症。在本病例报告中,我们描述了一位67岁的洪水综合征患者,他最初在一家由初级保健医生经营的社区医院接受保守治疗,然后转到一家三级医院接受专科手术检查和治疗。我们还对目前治疗这种疾病的方法进行了文献回顾。
{"title":"Flood Syndrome.","authors":"Jia Li Lee,&nbsp;Jeffrey Jiang","doi":"10.14740/gr1508","DOIUrl":"https://doi.org/10.14740/gr1508","url":null,"abstract":"<p><p>Flood syndrome refers to the exsanguination of ascitic fluid following the spontaneous rupture of an umbilical hernia, and is a rare complication of liver cirrhosis with ascites. In this case report, we describe a 67-year-old patient with Flood syndrome who was initially managed conservatively in a community hospital run by primary care physicians, prior to transfer to a tertiary hospital for specialist surgical review and management. We also performed a literature review of the current treatment modalities to manage this condition.</p>","PeriodicalId":12461,"journal":{"name":"Gastroenterology Research","volume":"15 4","pages":"217-224"},"PeriodicalIF":1.5,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/08/a7/gr-15-217.PMC9451583.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40372606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Transnasal Endoscopy for Children and Adolescents With Eosinophilic Esophagitis: A Single-Center Experience. 儿童和青少年嗜酸性食管炎的经鼻内窥镜检查:单中心经验。
IF 1.5 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2022-08-01 Epub Date: 2022-08-23 DOI: 10.14740/gr1535
Ramy Mahmoud Mohamed Sabe, Alaa Elzayat, Andrew Buckley, Jay Rajendra Shah, Ali Salar Khalili, Thomas Joseph Sferra

Background: Transnasal endoscopy (TNE) has been introduced in the care of pediatric patients with eosinophilic esophagitis (EoE) who require repeated esophagoscopies. TNE, as compared to conventional endoscopy, is less invasive and avoids sedation or anesthesia allowing for frequent assessments of the esophageal mucosa when making management decisions. The aim of this study is to review our early experience with TNE.

Methods: We extracted data from all patients with EoE who underwent TNE at UH Rainbow Babies & Children's Hospital, Cleveland, Ohio from December 2018 to April 2021. We assessed total visit time, procedure time, success rate, and complications. Data are presented as percentages or medians with interquartile ranges (IQRs). Comparisons were made using Chi-square (and Fisher's exact) test for categorical data, Mann-Whitney test and the unpaired t-test for non-normally distributed and normally distributed data, respectively.

Results: Thirty-three patients underwent 65 TNE procedures during our study period. The male-to-female ratio was 4.5:1 and median age was 13 years (IQR: 10 - 15 years; range: 4 - 20 years). Sixty-three (96.9%) of 65 procedures were completed. Distraction methods were used in all procedures (virtual reality goggles in 19.3% and television in 80.7%). Isolated elevated blood pressure (BP) measurements prior to the procedure were more frequent in those undergoing TNE as compared to sedated esophagogastroduodenoscopy (P = 0.04). We also calculated the heart rate (HR) for patients undergoing TNE and sedated upper endoscopy; no difference was noted (P = 0.71). Only minor adverse events occurred with TNE: nosebleed (n = 1), pre-syncope (n = 1), and pain (n = 4). None of the patients who underwent a sedated upper endoscopy developed an event. Two TNE procedures were not completed due to an inability to traverse the upper esophageal sphincter.

Conclusions: We demonstrate TNE is an efficient and well-tolerated means of monitoring patients with EoE. Various straight forward distraction methods may contribute to the successful completion of the procedure. The safety as compared to conventional esophagoscopy requires large multicenter studies.

背景:经鼻内镜(TNE)已被引入到需要反复食管镜检查的嗜酸性食管炎(EoE)患儿的护理中。与传统内窥镜检查相比,TNE的侵入性较小,避免了镇静或麻醉,在做出治疗决定时可以频繁评估食管黏膜。本研究的目的是回顾我们对创伤性精神创伤的早期经验。方法:我们从2018年12月至2021年4月在俄亥俄州克利夫兰的UH彩虹婴儿和儿童医院接受TNE治疗的所有EoE患者中提取数据。我们评估了总就诊时间、手术时间、成功率和并发症。数据以百分比或四分位数区间(IQRs)的中位数表示。对分类数据分别使用卡方(和Fisher’s exact)检验,对非正态分布和正态分布数据分别使用Mann-Whitney检验和unpaired t检验进行比较。结果:在我们的研究期间,33例患者接受了65例TNE手术。男女比例为4.5:1,中位年龄为13岁(IQR: 10 - 15岁;范围:4 - 20年)。65例手术中63例(96.9%)完成。所有手术均采用分心方法(虚拟现实护目镜占19.3%,电视占80.7%)。与镇静的食管胃十二指肠镜检查相比,术前单独血压升高(BP)在TNE患者中更常见(P = 0.04)。我们还计算了接受TNE和镇静上内窥镜检查的患者的心率(HR);差异无统计学意义(P = 0.71)。TNE只发生了轻微的不良事件:鼻出血(n = 1)、先兆晕厥(n = 1)和疼痛(n = 4)。接受镇静上腔镜检查的患者均未发生不良事件。由于无法穿过食管上括约肌,两例TNE手术未能完成。结论:我们证明TNE是一种有效且耐受性良好的监测EoE患者的方法。各种直接的分散方法可能有助于手术的成功完成。与传统食管镜检查相比,其安全性需要大规模的多中心研究。
{"title":"Transnasal Endoscopy for Children and Adolescents With Eosinophilic Esophagitis: A Single-Center Experience.","authors":"Ramy Mahmoud Mohamed Sabe,&nbsp;Alaa Elzayat,&nbsp;Andrew Buckley,&nbsp;Jay Rajendra Shah,&nbsp;Ali Salar Khalili,&nbsp;Thomas Joseph Sferra","doi":"10.14740/gr1535","DOIUrl":"https://doi.org/10.14740/gr1535","url":null,"abstract":"<p><strong>Background: </strong>Transnasal endoscopy (TNE) has been introduced in the care of pediatric patients with eosinophilic esophagitis (EoE) who require repeated esophagoscopies. TNE, as compared to conventional endoscopy, is less invasive and avoids sedation or anesthesia allowing for frequent assessments of the esophageal mucosa when making management decisions. The aim of this study is to review our early experience with TNE.</p><p><strong>Methods: </strong>We extracted data from all patients with EoE who underwent TNE at UH Rainbow Babies & Children's Hospital, Cleveland, Ohio from December 2018 to April 2021. We assessed total visit time, procedure time, success rate, and complications. Data are presented as percentages or medians with interquartile ranges (IQRs). Comparisons were made using Chi-square (and Fisher's exact) test for categorical data, Mann-Whitney test and the unpaired <i>t</i>-test for non-normally distributed and normally distributed data, respectively.</p><p><strong>Results: </strong>Thirty-three patients underwent 65 TNE procedures during our study period. The male-to-female ratio was 4.5:1 and median age was 13 years (IQR: 10 - 15 years; range: 4 - 20 years). Sixty-three (96.9%) of 65 procedures were completed. Distraction methods were used in all procedures (virtual reality goggles in 19.3% and television in 80.7%). Isolated elevated blood pressure (BP) measurements prior to the procedure were more frequent in those undergoing TNE as compared to sedated esophagogastroduodenoscopy (P = 0.04). We also calculated the heart rate (HR) for patients undergoing TNE and sedated upper endoscopy; no difference was noted (P = 0.71). Only minor adverse events occurred with TNE: nosebleed (n = 1), pre-syncope (n = 1), and pain (n = 4). None of the patients who underwent a sedated upper endoscopy developed an event. Two TNE procedures were not completed due to an inability to traverse the upper esophageal sphincter.</p><p><strong>Conclusions: </strong>We demonstrate TNE is an efficient and well-tolerated means of monitoring patients with EoE. Various straight forward distraction methods may contribute to the successful completion of the procedure. The safety as compared to conventional esophagoscopy requires large multicenter studies.</p>","PeriodicalId":12461,"journal":{"name":"Gastroenterology Research","volume":"15 4","pages":"155-161"},"PeriodicalIF":1.5,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/64/b1/gr-15-155.PMC9451578.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40372610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Association of Smoking and E-Cigarette in Chronic Liver Disease: An NHANES Study. 吸烟和电子烟与慢性肝病的关系:一项NHANES研究。
IF 1.5 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2022-06-01 DOI: 10.14740/gr1490
Raja Chandra Chakinala, Sameer Dawoodi, Stephanie P Fabara, Muhammad Asad, Azadeh Khayyat, Sangeetha Chandramohan, Aysha Aslam, Nkechi Unachukwu, Bibimariyam Nasyrlaeva, Richa Jaiswal, Sriram B Chowdary, Preeti Malik, Rizwan Rabbani

Background: There is an increased trend of e-cigarette but the toxic effects of e-cigarette metabolites are not widely studied especially in liver disease. Hence, we aimed to evaluate the prevalence and patterns of recent e-cigarette use in a nationally representative sample of US adults and adolescents and its association amongst respondents with liver disease.

Methods: We conducted a retrospective cross-sectional study using National Health and Nutrition Examination Survey (NHANES) database from 2015 to 2018. The self-reported NHANES questionnaire was used to assess liver disease (MCQ160L, MCQ170L and MCQ 510 (a-e)), e-cigarette use (SMQ900) and traditional smoking status (SMQ020 or SMQ040). We conducted univariate analysis and multivariable logistic regression models to predict the association of e-cigarette use, traditional smoking and dual smoking amongst the population with liver disease.

Results: Out of total 178,300 respondents, 7,756 (4.35%) were e-cigarette users, 48,625 (27.27%) traditional smoking, 23,444 (13.15%) dual smoking and 98,475 (55.23%) non-smokers. Females had a higher frequency of e-cigarette use (49.3%) compared to dual (43%) and traditional smoking (40.8%) (P < 0.0001). Respondents with a past history of any liver disease have lower frequency of e-cigarette use compared to dual and traditional smoking, respectively (2.4% vs. 6.4% vs. 7.2%; P < 0.0001). In multivariate logistic regression models, we found that e-cigarette users (odds ratio (OR): 1.06; 95% confidence interval (CI): 1.05 - 1.06; P < 0.0001) and dual smoking (OR: 1.50; 95% CI: 1.50 - 1.51; P < 0.0001) were associated with higher odds of having history of liver disease compared to non-smokers.

Conclusion: Our study found that despite the low frequency of e-cigarette use in respondents with liver disease, there was higher odds of e-cigarette use amongst patients with liver disease. This warrants the need for more future prospective studies to evaluate the long-term effects and precise mechanisms of e-cigarette toxicants on the liver.

背景:电子烟的使用呈增加趋势,但电子烟代谢物的毒性作用尚未得到广泛研究,特别是在肝病方面。因此,我们旨在评估美国成年人和青少年的全国代表性样本中近期电子烟使用的流行程度和模式,以及其与肝病受访者之间的关系。方法:利用2015 - 2018年国家健康与营养检查调查(NHANES)数据库进行回顾性横断面研究。采用自我报告的NHANES问卷评估肝脏疾病(MCQ160L、MCQ170L和mcq510 (a-e))、电子烟使用(SMQ900)和传统吸烟状况(SMQ020或SMQ040)。我们进行了单变量分析和多变量logistic回归模型来预测肝病人群中电子烟使用、传统吸烟和双重吸烟之间的关系。结果:在178,300名受访者中,7756人(4.35%)为电子烟使用者,48,625人(27.27%)为传统吸烟者,23,444人(13.15%)为双重吸烟者,98,475人(55.23%)为非吸烟者。女性使用电子烟的频率(49.3%)高于双烟(43%)和传统吸烟(40.8%)(P < 0.0001)。与双重吸烟和传统吸烟相比,有任何肝脏疾病病史的受访者使用电子烟的频率分别较低(2.4%对6.4%对7.2%;P < 0.0001)。在多元logistic回归模型中,我们发现电子烟使用者(优势比(OR): 1.06;95%置信区间(CI): 1.05 - 1.06;P < 0.0001)和双重吸烟(OR: 1.50;95% ci: 1.50 - 1.51;P < 0.0001)与不吸烟者相比,有肝脏疾病史的几率更高。结论:我们的研究发现,尽管肝病患者使用电子烟的频率较低,但肝病患者使用电子烟的几率更高。这证明了未来需要更多的前瞻性研究来评估电子烟毒素对肝脏的长期影响和确切机制。
{"title":"Association of Smoking and E-Cigarette in Chronic Liver Disease: An NHANES Study.","authors":"Raja Chandra Chakinala,&nbsp;Sameer Dawoodi,&nbsp;Stephanie P Fabara,&nbsp;Muhammad Asad,&nbsp;Azadeh Khayyat,&nbsp;Sangeetha Chandramohan,&nbsp;Aysha Aslam,&nbsp;Nkechi Unachukwu,&nbsp;Bibimariyam Nasyrlaeva,&nbsp;Richa Jaiswal,&nbsp;Sriram B Chowdary,&nbsp;Preeti Malik,&nbsp;Rizwan Rabbani","doi":"10.14740/gr1490","DOIUrl":"https://doi.org/10.14740/gr1490","url":null,"abstract":"<p><strong>Background: </strong>There is an increased trend of e-cigarette but the toxic effects of e-cigarette metabolites are not widely studied especially in liver disease. Hence, we aimed to evaluate the prevalence and patterns of recent e-cigarette use in a nationally representative sample of US adults and adolescents and its association amongst respondents with liver disease.</p><p><strong>Methods: </strong>We conducted a retrospective cross-sectional study using National Health and Nutrition Examination Survey (NHANES) database from 2015 to 2018. The self-reported NHANES questionnaire was used to assess liver disease (MCQ160L, MCQ170L and MCQ 510 (a-e)), e-cigarette use (SMQ900) and traditional smoking status (SMQ020 or SMQ040). We conducted univariate analysis and multivariable logistic regression models to predict the association of e-cigarette use, traditional smoking and dual smoking amongst the population with liver disease.</p><p><strong>Results: </strong>Out of total 178,300 respondents, 7,756 (4.35%) were e-cigarette users, 48,625 (27.27%) traditional smoking, 23,444 (13.15%) dual smoking and 98,475 (55.23%) non-smokers. Females had a higher frequency of e-cigarette use (49.3%) compared to dual (43%) and traditional smoking (40.8%) (P < 0.0001). Respondents with a past history of any liver disease have lower frequency of e-cigarette use compared to dual and traditional smoking, respectively (2.4% vs. 6.4% vs. 7.2%; P < 0.0001). In multivariate logistic regression models, we found that e-cigarette users (odds ratio (OR): 1.06; 95% confidence interval (CI): 1.05 - 1.06; P < 0.0001) and dual smoking (OR: 1.50; 95% CI: 1.50 - 1.51; P < 0.0001) were associated with higher odds of having history of liver disease compared to non-smokers.</p><p><strong>Conclusion: </strong>Our study found that despite the low frequency of e-cigarette use in respondents with liver disease, there was higher odds of e-cigarette use amongst patients with liver disease. This warrants the need for more future prospective studies to evaluate the long-term effects and precise mechanisms of e-cigarette toxicants on the liver.</p>","PeriodicalId":12461,"journal":{"name":"Gastroenterology Research","volume":"15 3","pages":"113-119"},"PeriodicalIF":1.5,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239491/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9665701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Seasonal Variations of Hospital Admissions for Alcohol-Related Hepatitis in the United States. 美国酒精相关肝炎入院人数的季节性变化。
IF 1.4 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2022-04-01 Epub Date: 2022-04-23 DOI: 10.14740/gr1506
Aalam Sohal, Kanwal Bains, Armaan Dhaliwal, Hunza Chaudhry, Raghav Sharma, Piyush Singla, Gagan Gupta, Dino Dukovic, Sunny Sandhu, Marina Roytman, Steven Tringali

Background: Clinical experience suggests an increased hospitalization rate for alcohol-related hepatitis (AH) in the winter months; however, seasonal variations in the prevalence of hospitalizations for AH have not been described previously. We hypothesized that AH hospitalizations would be higher in the winter months due to the holiday season and increased alcohol sales.

Methods: Patients with primary or secondary discharge diagnosis of AH were included in the study (International Classification of Diseases, Clinical Modification-10th Revision codes K70.4 and K70.1) between January 2016 and December 2019. The primary outcome measure for this study was daily hospitalizations by each month of the year. Secondary outcome measures included the rate of in-hospital mortality associated with AH, for each month.

Results: The highest number of AH-related admissions was reported in July (n = 56,800; 9%), followed by August (n = 55,700; 8.8%) and May (n = 54,865; 8.7%). February had the lowest number of admissions (n = 46,550; 7.37%). The adjusted mortality was highest in December (overall mortality: 9.6%; adjusted odds ratio: 1.29; 95% confidence interval: 1.142 - 1.461; P < 0.0001) and lowest in May (overall mortality rate: 7.7%). No difference was noted between length of stay and total hospitalization cost between months.

Conclusion: Our findings demonstrate that seasonal variations in hospitalizations related to AH do exist across the United States. Regional differences also exist and follow unique patterns. The increase in admissions for AH is in line with other studies suggesting that heavy drinking happens during the warm season. Hospital administrators and other stewards of healthcare resources can use seasonal patterns to guide allocation of resources.

背景:临床经验表明,酒精相关肝炎(AH)的住院率在冬季会有所上升;然而,此前并未描述过酒精相关肝炎住院率的季节性变化。我们假设,由于节假日和酒精销售量的增加,冬季的酒精相关性肝炎住院率会更高:研究纳入了 2016 年 1 月至 2019 年 12 月期间主要或次要出院诊断为 AH 的患者(《国际疾病分类、临床修订-10 次修订》代码 K70.4 和 K70.1)。本研究的主要结果测量指标是每年每月的日住院率。次要结果指标包括每月与 AH 相关的院内死亡率:与 AH 相关的住院人数最多的月份是 7 月(n = 56,800; 9%),其次是 8 月(n = 55,700; 8.8%)和 5 月(n = 54,865; 8.7%)。二月份的入院人数最少(人数=46,550;7.37%)。调整后的死亡率在 12 月份最高(总死亡率:9.6%;调整后的几率比:1.29;95% 置信区间:1.142 - 1.461;P < 0.0001),在 5 月份最低(总死亡率:7.7%)。不同月份的住院时间和住院总费用没有差异:我们的研究结果表明,在美国各地,与 AH 相关的住院治疗确实存在季节性差异。地区之间也存在差异,并遵循独特的模式。AH入院人数的增加与其他研究结果一致,表明在温暖的季节会出现大量饮酒的情况。医院管理者和其他医疗资源的管理者可以利用季节性模式来指导资源分配。
{"title":"Seasonal Variations of Hospital Admissions for Alcohol-Related Hepatitis in the United States.","authors":"Aalam Sohal, Kanwal Bains, Armaan Dhaliwal, Hunza Chaudhry, Raghav Sharma, Piyush Singla, Gagan Gupta, Dino Dukovic, Sunny Sandhu, Marina Roytman, Steven Tringali","doi":"10.14740/gr1506","DOIUrl":"10.14740/gr1506","url":null,"abstract":"<p><strong>Background: </strong>Clinical experience suggests an increased hospitalization rate for alcohol-related hepatitis (AH) in the winter months; however, seasonal variations in the prevalence of hospitalizations for AH have not been described previously. We hypothesized that AH hospitalizations would be higher in the winter months due to the holiday season and increased alcohol sales.</p><p><strong>Methods: </strong>Patients with primary or secondary discharge diagnosis of AH were included in the study (International Classification of Diseases, Clinical Modification-10th Revision codes K70.4 and K70.1) between January 2016 and December 2019. The primary outcome measure for this study was daily hospitalizations by each month of the year. Secondary outcome measures included the rate of in-hospital mortality associated with AH, for each month.</p><p><strong>Results: </strong>The highest number of AH-related admissions was reported in July (n = 56,800; 9%), followed by August (n = 55,700; 8.8%) and May (n = 54,865; 8.7%). February had the lowest number of admissions (n = 46,550; 7.37%). The adjusted mortality was highest in December (overall mortality: 9.6%; adjusted odds ratio: 1.29; 95% confidence interval: 1.142 - 1.461; P < 0.0001) and lowest in May (overall mortality rate: 7.7%). No difference was noted between length of stay and total hospitalization cost between months.</p><p><strong>Conclusion: </strong>Our findings demonstrate that seasonal variations in hospitalizations related to AH do exist across the United States. Regional differences also exist and follow unique patterns. The increase in admissions for AH is in line with other studies suggesting that heavy drinking happens during the warm season. Hospital administrators and other stewards of healthcare resources can use seasonal patterns to guide allocation of resources.</p>","PeriodicalId":12461,"journal":{"name":"Gastroenterology Research","volume":"15 1","pages":"75-81"},"PeriodicalIF":1.4,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076155/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67215833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Extremely Rare Case of Rectal Signet Ring Cell Carcinoma 直肠印戒细胞癌一例极为罕见
IF 1.5 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2022-04-01 DOI: 10.14740/gr1516
Woo Jin Seog, S. Dhruv, K. Atodaria, A. Polavarapu
Signet ring cell carcinoma of the rectum is a rare variant of colorectal cancer. When found, it is often diagnosed in late stages and has poor prognosis. This case depicts a patient with a history of Crohn’s disease who presented to the hospital for perirectal abscesses. During the evaluation of both the abscesses and Crohn’s disease, he was found to have stage IV adenocarcinoma with signet ring cell features. The patient was started on chemotherapy before surgical resection was considered, however, showed little response. The patient’s family eventually pursued hospice care with comfort measures only. Colorectal signet ring cell carcinoma is rare but has poor prognosis as it is diagnosed generally at late and advanced stages. There is a need for more research in earlier detection of these rare cancers.
直肠标志性环细胞癌是癌症的一种罕见变异。一旦发现,通常在晚期诊断,预后较差。该病例描述了一名有克罗恩病病史的患者,他因直肠周围脓肿到医院就诊。在对脓肿和克罗恩病的评估中,他被发现患有具有印戒细胞特征的IV期腺癌。患者在考虑手术切除前开始化疗,但反应甚微。病人的家人最终只采取了安慰措施来寻求临终关怀。结直肠癌印戒细胞癌是罕见的,但预后较差,因为它通常在晚期和晚期诊断。有必要对这些罕见癌症的早期检测进行更多的研究。
{"title":"An Extremely Rare Case of Rectal Signet Ring Cell Carcinoma","authors":"Woo Jin Seog, S. Dhruv, K. Atodaria, A. Polavarapu","doi":"10.14740/gr1516","DOIUrl":"https://doi.org/10.14740/gr1516","url":null,"abstract":"Signet ring cell carcinoma of the rectum is a rare variant of colorectal cancer. When found, it is often diagnosed in late stages and has poor prognosis. This case depicts a patient with a history of Crohn’s disease who presented to the hospital for perirectal abscesses. During the evaluation of both the abscesses and Crohn’s disease, he was found to have stage IV adenocarcinoma with signet ring cell features. The patient was started on chemotherapy before surgical resection was considered, however, showed little response. The patient’s family eventually pursued hospice care with comfort measures only. Colorectal signet ring cell carcinoma is rare but has poor prognosis as it is diagnosed generally at late and advanced stages. There is a need for more research in earlier detection of these rare cancers.","PeriodicalId":12461,"journal":{"name":"Gastroenterology Research","volume":"15 1","pages":"106 - 111"},"PeriodicalIF":1.5,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42641194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The Incidence of Venous Thromboembolism and Practice of Deep Venous Thrombosis Prophylaxis Among Hospitalized Cirrhotic Patients 住院肝硬化患者静脉血栓栓塞发生率及深静脉血栓预防实践
IF 1.5 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2022-04-01 DOI: 10.14740/gr1493
Mira Alsheikh, K. Kamar, Malek Kreidieh, Rola Sasso, Samragnyi Madala, Rubal Sharma, Hassan Al Moussawi, L. Deeb
Background Patients with liver cirrhosis have altered hepatic synthetic functions which theoretically result in reduced levels of pro-and anti-coagulant factors as well as thrombocytopenia. Initially, cirrhotic patients were thought to be at an increased risk of bleeding and a reduced risk of thrombosis. Several studies have recently reported an increased occurrence of venous thromboembolism (VTE) in cirrhotic patients. In this study, we aimed to assess the current practice of deep venous thrombosis (DVT) prophylaxis, the incidence and predictors of VTE, and the associated bleeding sequelae in patients with liver cirrhosis. Methods A retrospective cohort study was performed. We included all adult patients with a diagnosis of liver cirrhosis from January 2010 to June 2019 admitted to the hospital. Our cohort patients were divided into two groups, cirrhotic patients with pharmacological VTE prophylaxis and those with mechanical or no VTE prophylaxis. Results We included 601 cirrhotic patients in our study. The incidence of VTE occurring within the first 6 months of their admission was 1.5%. Seven patients (1.49%) developed VTE with the majority being DVTs while not on pharmacologic prophylaxis, and two patients developed VTE despite being on pharmacologic prophylaxis; however, there was no statistical difference. Alcohol use was the most common underlying cause of liver cirrhosis (40.4%), followed by chronic hepatitis C (21.1%), and nonalcoholic steatohepatitis (11.3%). Out of the 601 patients included, 69 patients received neither pharmacologic nor mechanical VTE prophylactic agent (11.48%), while the remaining majority received either pharmacological or mechanical prophylaxis (88.52%). Conclusions Our study did not show a statistically significant association between the use of pharmacological VTE prophylactic agents and a reduction in the risk of VTE in cirrhotic patients. The rates of usage of DVT prophylactic agents among our Northwell hospitals during the study period appeared to be no longer suboptimal when compared to prior studies. Low albumin appears to be a predictor factor to develop VTE. There was a statistically significant increase in bleeding risk and transfusion requirement in cirrhotic patients receiving no pharmacological VTE prophylactic agents. Further prospective trials are needed to shed more light on this subject and identify the group of cirrhotic patients who could safely benefit from pharmacologic VTE prophylaxis.
背景肝硬化患者的肝脏合成功能发生了改变,理论上导致促凝血因子和抗凝血因子水平降低以及血小板减少。最初,肝硬化患者被认为出血风险增加,血栓形成风险降低。最近几项研究报告了肝硬化患者静脉血栓栓塞(VTE)的发生率增加。在本研究中,我们旨在评估肝硬化患者预防深静脉血栓形成(DVT)的当前实践、VTE的发生率和预测因素,以及相关的出血后遗症。方法采用回顾性队列研究。我们纳入了2010年1月至2019年6月入院的所有诊断为肝硬化的成年患者。我们的队列患者被分为两组,一组是药物预防性VTE的肝硬化患者,另一组是机械或无VTE预防的肝硬化患者。结果本研究纳入601例肝硬化患者。VTE发生在入院后的前6个月内的发生率为1.5%。7名患者(1.49%)发生了VTE,其中大多数是未进行药物预防的DVT,2名患者尽管进行了药物预防,但仍发生了VTE;但没有统计学差异。饮酒是肝硬化最常见的潜在原因(40.4%),其次是慢性丙型肝炎(21.1%)和非酒精性脂肪性肝炎(11.3%)。在601名患者中,69名患者既没有服用药物也没有服用机械性VTE预防剂(11.48%),而其余大多数患者接受了药物或机械预防(88.52%)。结论我们的研究没有显示使用药物VTE预防剂与降低肝硬化患者VTE风险之间的统计学显著相关性。与之前的研究相比,在研究期间,我们的Northwell医院中DVT预防剂的使用率似乎不再是次优的。低白蛋白似乎是发生VTE的一个预测因素。在没有服用药物VTE预防剂的肝硬化患者中,出血风险和输血需求在统计学上显著增加。需要进一步的前瞻性试验来阐明这一主题,并确定可以安全地从药物VTE预防中获益的肝硬化患者群体。
{"title":"The Incidence of Venous Thromboembolism and Practice of Deep Venous Thrombosis Prophylaxis Among Hospitalized Cirrhotic Patients","authors":"Mira Alsheikh, K. Kamar, Malek Kreidieh, Rola Sasso, Samragnyi Madala, Rubal Sharma, Hassan Al Moussawi, L. Deeb","doi":"10.14740/gr1493","DOIUrl":"https://doi.org/10.14740/gr1493","url":null,"abstract":"Background Patients with liver cirrhosis have altered hepatic synthetic functions which theoretically result in reduced levels of pro-and anti-coagulant factors as well as thrombocytopenia. Initially, cirrhotic patients were thought to be at an increased risk of bleeding and a reduced risk of thrombosis. Several studies have recently reported an increased occurrence of venous thromboembolism (VTE) in cirrhotic patients. In this study, we aimed to assess the current practice of deep venous thrombosis (DVT) prophylaxis, the incidence and predictors of VTE, and the associated bleeding sequelae in patients with liver cirrhosis. Methods A retrospective cohort study was performed. We included all adult patients with a diagnosis of liver cirrhosis from January 2010 to June 2019 admitted to the hospital. Our cohort patients were divided into two groups, cirrhotic patients with pharmacological VTE prophylaxis and those with mechanical or no VTE prophylaxis. Results We included 601 cirrhotic patients in our study. The incidence of VTE occurring within the first 6 months of their admission was 1.5%. Seven patients (1.49%) developed VTE with the majority being DVTs while not on pharmacologic prophylaxis, and two patients developed VTE despite being on pharmacologic prophylaxis; however, there was no statistical difference. Alcohol use was the most common underlying cause of liver cirrhosis (40.4%), followed by chronic hepatitis C (21.1%), and nonalcoholic steatohepatitis (11.3%). Out of the 601 patients included, 69 patients received neither pharmacologic nor mechanical VTE prophylactic agent (11.48%), while the remaining majority received either pharmacological or mechanical prophylaxis (88.52%). Conclusions Our study did not show a statistically significant association between the use of pharmacological VTE prophylactic agents and a reduction in the risk of VTE in cirrhotic patients. The rates of usage of DVT prophylactic agents among our Northwell hospitals during the study period appeared to be no longer suboptimal when compared to prior studies. Low albumin appears to be a predictor factor to develop VTE. There was a statistically significant increase in bleeding risk and transfusion requirement in cirrhotic patients receiving no pharmacological VTE prophylactic agents. Further prospective trials are needed to shed more light on this subject and identify the group of cirrhotic patients who could safely benefit from pharmacologic VTE prophylaxis.","PeriodicalId":12461,"journal":{"name":"Gastroenterology Research","volume":"15 1","pages":"67 - 74"},"PeriodicalIF":1.5,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43577880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Video Capsule Endoscopy in Gastroenterology 视频胶囊内镜在胃肠病学中的应用
IF 1.5 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2022-04-01 DOI: 10.14740/gr1487
Monjur Ahmed
Video capsule endoscopy (VCE) is a wireless technology used by gastroenterologists for various indications in their clinical practice. There has been significant improvement in this technology since its start about two decades ago. Specific video capsules have been made to evaluate the small bowel, colon, and esophagus. Now pan-enteric video capsule is available to assess both the small bowel and colon. VCE is a non-invasive procedure that has been tremendously evaluated for various gastrointestinal disorders, particularly small intestinal bleeding. There are specific contraindications and complications of VCE. This procedure has the technical part and video reading part. Newer software programs will come to reduce the reading time. Artificial intelligence is also coming for quick and accurate diagnosis of any positive findings during VCE. VCE is an important diagnostic test in the field of gastroenterology. Although it is an addition to optical endoscopic procedures to visualize the gastrointestinal mucosa, it has advantages and disadvantages.
视频胶囊内窥镜(VCE)是胃肠病学家在临床实践中用于各种适应症的无线技术。这项技术自20年前问世以来已经有了显著的进步。已经制作了专门的视频胶囊来评估小肠、结肠和食道。现在,泛肠视频胶囊可用于评估小肠和结肠。VCE是一种非侵入性手术,已被广泛应用于各种胃肠道疾病,特别是小肠出血。VCE有特定的禁忌症和并发症。本程序分为技术部分和视频读取部分。更新的软件程序将会减少阅读时间。人工智能也用于快速准确地诊断VCE期间的任何阳性结果。VCE是胃肠病学领域一项重要的诊断试验。虽然它是一种附加的光学内镜程序,以可视化胃肠道粘膜,它有优点和缺点。
{"title":"Video Capsule Endoscopy in Gastroenterology","authors":"Monjur Ahmed","doi":"10.14740/gr1487","DOIUrl":"https://doi.org/10.14740/gr1487","url":null,"abstract":"Video capsule endoscopy (VCE) is a wireless technology used by gastroenterologists for various indications in their clinical practice. There has been significant improvement in this technology since its start about two decades ago. Specific video capsules have been made to evaluate the small bowel, colon, and esophagus. Now pan-enteric video capsule is available to assess both the small bowel and colon. VCE is a non-invasive procedure that has been tremendously evaluated for various gastrointestinal disorders, particularly small intestinal bleeding. There are specific contraindications and complications of VCE. This procedure has the technical part and video reading part. Newer software programs will come to reduce the reading time. Artificial intelligence is also coming for quick and accurate diagnosis of any positive findings during VCE. VCE is an important diagnostic test in the field of gastroenterology. Although it is an addition to optical endoscopic procedures to visualize the gastrointestinal mucosa, it has advantages and disadvantages.","PeriodicalId":12461,"journal":{"name":"Gastroenterology Research","volume":"15 1","pages":"47 - 55"},"PeriodicalIF":1.5,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67216137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Burden and Predictors of Non-Alcoholic Fatty Liver Disease in a Retrospective Cohort of Patients With Crohn’s Disease 回顾性克罗恩病患者非酒精性脂肪性肝病的负担和预测因素
IF 1.5 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2022-04-01 DOI: 10.14740/gr1509
A. Abomhya, Mohammed Mahmoodurrahman, Salman Ayaz, H. Hamad, F. Khan
Background Non-alcoholic fatty liver disease (NAFLD) is an emerging extraintestinal manifestation (EIM) of Crohn’s disease (CD). We aimed to investigate the prevalence and comorbid predictors of NAFLD in patients with CD. Methods We conducted a nationwide retrospective cohort study to determine the prevalence, characteristics, comorbidities, and hospitalization outcomes associated with NAFLD in patients with CD. Comparison between groups was performed by Mann-Whitney test for continuous variables and Chi-square test for categorical variables. We performed a binary logistic regression analysis for predictors of NAFLD among patients with CD. Results We extracted 215,049 index hospital discharges with CD; 2.4% had NAFLD. CD patients, with NAFLD, had increased length of stay (4 days; interquartile range (IQR): 2 - 6 vs. 3; IQR: 2 - 6, P < 0.01), and increased median total charges ($32,305.5; IQR: $18,600 - $61,599 vs. $30,782; IQR: $16,847 - $58,667, P < 0.01), compared to CD patients without NAFLD. Non-alcoholic steatohepatitis (NASH) was found to be independently associated with increased mortality (odds ratio (OR): 1.7; 95% confidence interval (CI): 1.1 - 2.6, P = 0.03) and a higher odd for all-cause 30-day non-elective readmission (OR: 1.6: 95% CI: 1.3 - 1.9, P < 0.001). Factors independently associated with NAFLD in patients with CD included portal hypertension (OR: 5.347; 95% CI: 4.604 - 6.211, P < 0.001), vitamin A deficiency (OR: 9.89; 95% CI: 4.49 - 21.76, P < 0.001) and vitamin B12 deficiency (OR: 1.56; 95% CI: 1.098 - 2.209, P = 0.013). Conclusions NAFLD is associated with worse hospitalization outcomes in patients with CD. Study findings suggest the need for early identification and effective management of NAFLD predictors to reduce complications.
非酒精性脂肪性肝病(NAFLD)是克罗恩病(CD)的一种新出现的肠外表现(EIM)。我们的目的是研究CD患者NAFLD的患病率和共病预测因素。方法我们进行了一项全国性的回顾性队列研究,以确定CD患者NAFLD的患病率、特征、合并症和住院结果。组间比较采用连续变量的Mann-Whitney检验和分类变量的卡方检验。我们对CD患者中NAFLD的预测因素进行了二元logistic回归分析。结果我们提取了215049例CD患者出院指数;2.4%为NAFLD。合并NAFLD的CD患者住院时间增加(4天;四分位间距(IQR): 2 - 6 vs. 3;IQR: 2 - 6, P < 0.01),总收费中位数增加(32,305.5美元;IQR: 18,600美元- 61,599美元vs. 30,782美元;IQR: $16,847 - $58,667, P < 0.01),与非NAFLD的CD患者相比。非酒精性脂肪性肝炎(NASH)被发现与死亡率增加独立相关(优势比(OR): 1.7;95%可信区间(CI): 1.1 - 2.6, P = 0.03),全因30天非选择性再入院的奇率更高(OR: 1.6; 95% CI: 1.3 - 1.9, P < 0.001)。与乳糜泻患者NAFLD独立相关的因素包括门脉高压(OR: 5.347;95% CI: 4.604 - 6.211, P < 0.001),维生素A缺乏(OR: 9.89;95% CI: 4.49 - 21.76, P < 0.001)和维生素B12缺乏(OR: 1.56;95% ci: 1.098 - 2.209, p = 0.013)。结论:NAFLD与CD患者较差的住院结果相关。研究结果表明,需要早期识别和有效管理NAFLD预测因子,以减少并发症。
{"title":"Burden and Predictors of Non-Alcoholic Fatty Liver Disease in a Retrospective Cohort of Patients With Crohn’s Disease","authors":"A. Abomhya, Mohammed Mahmoodurrahman, Salman Ayaz, H. Hamad, F. Khan","doi":"10.14740/gr1509","DOIUrl":"https://doi.org/10.14740/gr1509","url":null,"abstract":"Background Non-alcoholic fatty liver disease (NAFLD) is an emerging extraintestinal manifestation (EIM) of Crohn’s disease (CD). We aimed to investigate the prevalence and comorbid predictors of NAFLD in patients with CD. Methods We conducted a nationwide retrospective cohort study to determine the prevalence, characteristics, comorbidities, and hospitalization outcomes associated with NAFLD in patients with CD. Comparison between groups was performed by Mann-Whitney test for continuous variables and Chi-square test for categorical variables. We performed a binary logistic regression analysis for predictors of NAFLD among patients with CD. Results We extracted 215,049 index hospital discharges with CD; 2.4% had NAFLD. CD patients, with NAFLD, had increased length of stay (4 days; interquartile range (IQR): 2 - 6 vs. 3; IQR: 2 - 6, P < 0.01), and increased median total charges ($32,305.5; IQR: $18,600 - $61,599 vs. $30,782; IQR: $16,847 - $58,667, P < 0.01), compared to CD patients without NAFLD. Non-alcoholic steatohepatitis (NASH) was found to be independently associated with increased mortality (odds ratio (OR): 1.7; 95% confidence interval (CI): 1.1 - 2.6, P = 0.03) and a higher odd for all-cause 30-day non-elective readmission (OR: 1.6: 95% CI: 1.3 - 1.9, P < 0.001). Factors independently associated with NAFLD in patients with CD included portal hypertension (OR: 5.347; 95% CI: 4.604 - 6.211, P < 0.001), vitamin A deficiency (OR: 9.89; 95% CI: 4.49 - 21.76, P < 0.001) and vitamin B12 deficiency (OR: 1.56; 95% CI: 1.098 - 2.209, P = 0.013). Conclusions NAFLD is associated with worse hospitalization outcomes in patients with CD. Study findings suggest the need for early identification and effective management of NAFLD predictors to reduce complications.","PeriodicalId":12461,"journal":{"name":"Gastroenterology Research","volume":"15 1","pages":"82 - 90"},"PeriodicalIF":1.5,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46595725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Trends and Outcomes of Alcoholic Liver Cirrhosis Hospitalizations in the Last Two Decades: Analysis of the Nationwide Inpatient Sample 近二十年酒精性肝硬化住院的趋势和结果:全国住院患者样本分析
IF 1.5 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2022-04-01 DOI: 10.14740/gr1517
H. Laswi, Abdul-rahman Abusalim, Muhammad-Sheharyar Warraich, Katayoun Khoshbin, H. Shaka
Background Liver cirrhosis is a major burden on the health care system. Alcohol is one of the most common etiologies of cirrhosis. The aim of our article is to examine the trends of alcoholic liver cirrhosis (ALC) hospitalizations over the past two decades. Methods This was a retrospective longitudinal study. Using the International Classification of Diseases, Ninth Revision, Clinical Modification/Procedure Coding System (ICD-9-CM/PCS) and the ICD-10-CM/PCS, the Nationwide Inpatient Sample (NIS) database was analyzed. We included 1998, 2003, 2008, 2013, and 2018 NIS databases. Using multivariate regression analysis, we examined trends of ALC hospitalizations including inpatient mortality, mean length of stay (LOS), and mean total hospital charges (THCs). Results We included 261,420 hospitalizations with ALC as the primary diagnosis for admission. There was a trend toward increasing hospitalizations over that period; they increased from 46,186 in 1998 to 69,970 in 2018 (P < 0.001). Moreover, there was a 2.1-fold increase in the mean THC in 2018 compared to 1998 (P < 0.001). On the other hand, inpatient mortality decreased from 12.8% in 1998 to 4.7% in 2018 (P < 0.001), and a trend of decreasing mean LOS was observed. The mean LOS decreased from 7.0 days in 1998 to 5.9 days in 2018 (P < 0.001). Conclusions Over the last two decades, there was a trend of increasing hospitalizations and THC. However, we noticed a trend toward decreasing inpatient mortality and LOS over that period, which might reflect in part an improvement in the medical care provided for these patients.
背景肝硬化是医疗保健系统的主要负担。酒精是肝硬化最常见的病因之一。我们文章的目的是研究过去二十年来酒精性肝硬化(ALC)住院的趋势。方法采用回顾性纵向研究。使用国际疾病分类第九次修订、临床修改/程序编码系统(ICD-9-CM/PCS)和ICD-10-CM/PCS,分析了全国住院患者样本(NIS)数据库。我们包括1998年、2003年、2008年、2013年和2018年NIS数据库。使用多元回归分析,我们检查了ALC住院的趋势,包括住院死亡率、平均住院时间(LOS)和平均总住院费用(THCs)。结果我们纳入了261420例以ALC为主要入院诊断的住院患者。在此期间,住院人数有增加的趋势;他们从1998年的46186人增加到2018年的69970人(P<0.001)。此外,与1998年相比,2018年的平均THC增加了2.1倍(P<0.001。平均LOS从1998年的7.0天下降到2018年的5.9天(P<0.001)。结论在过去20年中,住院人数和THC有增加的趋势。然而,我们注意到,在这段时间内,住院死亡率和服务水平呈下降趋势,这可能在一定程度上反映了为这些患者提供的医疗服务的改善。
{"title":"Trends and Outcomes of Alcoholic Liver Cirrhosis Hospitalizations in the Last Two Decades: Analysis of the Nationwide Inpatient Sample","authors":"H. Laswi, Abdul-rahman Abusalim, Muhammad-Sheharyar Warraich, Katayoun Khoshbin, H. Shaka","doi":"10.14740/gr1517","DOIUrl":"https://doi.org/10.14740/gr1517","url":null,"abstract":"Background Liver cirrhosis is a major burden on the health care system. Alcohol is one of the most common etiologies of cirrhosis. The aim of our article is to examine the trends of alcoholic liver cirrhosis (ALC) hospitalizations over the past two decades. Methods This was a retrospective longitudinal study. Using the International Classification of Diseases, Ninth Revision, Clinical Modification/Procedure Coding System (ICD-9-CM/PCS) and the ICD-10-CM/PCS, the Nationwide Inpatient Sample (NIS) database was analyzed. We included 1998, 2003, 2008, 2013, and 2018 NIS databases. Using multivariate regression analysis, we examined trends of ALC hospitalizations including inpatient mortality, mean length of stay (LOS), and mean total hospital charges (THCs). Results We included 261,420 hospitalizations with ALC as the primary diagnosis for admission. There was a trend toward increasing hospitalizations over that period; they increased from 46,186 in 1998 to 69,970 in 2018 (P < 0.001). Moreover, there was a 2.1-fold increase in the mean THC in 2018 compared to 1998 (P < 0.001). On the other hand, inpatient mortality decreased from 12.8% in 1998 to 4.7% in 2018 (P < 0.001), and a trend of decreasing mean LOS was observed. The mean LOS decreased from 7.0 days in 1998 to 5.9 days in 2018 (P < 0.001). Conclusions Over the last two decades, there was a trend of increasing hospitalizations and THC. However, we noticed a trend toward decreasing inpatient mortality and LOS over that period, which might reflect in part an improvement in the medical care provided for these patients.","PeriodicalId":12461,"journal":{"name":"Gastroenterology Research","volume":"15 1","pages":"91 - 99"},"PeriodicalIF":1.5,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41415654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Extensive Aortic Thrombosis and Renal Infarction in Association With an Active Flare-Up of Crohn’s Disease 广泛的主动脉血栓形成和肾梗死与克罗恩病的急性发作有关
IF 1.5 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2022-03-12 DOI: 10.14740/gr1504
Eltaib A Saad, Abdalaziz Awadelkarim, M. Agab, Akram Babkir
Venous thromboembolism (VTE) is a recognized extraintestinal manifestation of inflammatory bowel disease (IBD), with deep venous thrombosis (DVT) and pulmonary embolism being reported as the most frequent vascular complications in IBD patients. Much less frequently, arterial thromboembolic events may also be associated with greater morbidity and mortality. Aortic mural thrombosis is a rare phenomenon described in patients with IBD that often results in serious consequences such as visceral infarction and acute ischemia of the lower extremities. We described an unusual case of a female patient with Crohn’s disease (CD) who presented with generalized abdominal pain and vomiting. Imaging showed an active flare-up of intestinal CD as well as two mural thrombi in the distal descending thoracic aorta and the abdominal aorta at the level of the left renal artery, respectively, with a left renal infarction. The mesenteric angiogram revealed a patent celiac axis and mesenteric arteries. The patient was therapeutically anticoagulated, and she underwent a right hemicolectomy for the perforated ileal disease. A comprehensive diagnostic workup for hypercoagulability and thrombophilia was negative for an underlying etiology, and the active CD flare-up was considered the main culprit triggering the aortic thrombosis in this reported patient. Our case highlighted the occurrence of aortic thrombosis in a patient with IBD and that entails careful attention. Early recognition and timely management with a multidisciplinary team is the key to improving the outcome of aortic events that coincide with the active flare-up of IBD.
静脉血栓栓塞症(VTE)是炎症性肠病(IBD)的一种公认的肠外表现,据报道,深静脉血栓形成(DVT)和肺栓塞是IBD患者最常见的血管并发症。动脉血栓栓塞事件的发生率要低得多,也可能与更高的发病率和死亡率有关。主动脉壁血栓形成是IBD患者中罕见的现象,通常会导致严重后果,如内脏梗死和下肢急性缺血。我们描述了一例罕见的克罗恩病(CD)女性患者,其表现为全身性腹痛和呕吐。影像学显示肠CD活跃发作,左肾动脉水平的胸降主动脉和腹主动脉远端分别有两处壁血栓,并伴有左肾梗死。肠系膜血管造影显示腹腔轴和肠系膜动脉未闭。患者接受了治疗性抗凝治疗,并因回肠穿孔接受了右半结肠切除术。高凝状态和易血栓形成的综合诊断检查对潜在病因呈阴性,活动性CD发作被认为是引发该报告患者主动脉血栓形成的主要原因。我们的病例强调了IBD患者主动脉血栓形成的发生,这需要仔细注意。多学科团队的早期识别和及时管理是改善IBD活跃发作时主动脉事件结果的关键。
{"title":"Extensive Aortic Thrombosis and Renal Infarction in Association With an Active Flare-Up of Crohn’s Disease","authors":"Eltaib A Saad, Abdalaziz Awadelkarim, M. Agab, Akram Babkir","doi":"10.14740/gr1504","DOIUrl":"https://doi.org/10.14740/gr1504","url":null,"abstract":"Venous thromboembolism (VTE) is a recognized extraintestinal manifestation of inflammatory bowel disease (IBD), with deep venous thrombosis (DVT) and pulmonary embolism being reported as the most frequent vascular complications in IBD patients. Much less frequently, arterial thromboembolic events may also be associated with greater morbidity and mortality. Aortic mural thrombosis is a rare phenomenon described in patients with IBD that often results in serious consequences such as visceral infarction and acute ischemia of the lower extremities. We described an unusual case of a female patient with Crohn’s disease (CD) who presented with generalized abdominal pain and vomiting. Imaging showed an active flare-up of intestinal CD as well as two mural thrombi in the distal descending thoracic aorta and the abdominal aorta at the level of the left renal artery, respectively, with a left renal infarction. The mesenteric angiogram revealed a patent celiac axis and mesenteric arteries. The patient was therapeutically anticoagulated, and she underwent a right hemicolectomy for the perforated ileal disease. A comprehensive diagnostic workup for hypercoagulability and thrombophilia was negative for an underlying etiology, and the active CD flare-up was considered the main culprit triggering the aortic thrombosis in this reported patient. Our case highlighted the occurrence of aortic thrombosis in a patient with IBD and that entails careful attention. Early recognition and timely management with a multidisciplinary team is the key to improving the outcome of aortic events that coincide with the active flare-up of IBD.","PeriodicalId":12461,"journal":{"name":"Gastroenterology Research","volume":"15 1","pages":"100 - 105"},"PeriodicalIF":1.5,"publicationDate":"2022-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49104086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Gastroenterology Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1